Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Orexigen Therapeutics Inc.

www.orexigen.com

Latest From Redx Pharma PLC

Deal Watch: GSK Declines Option As Ionis' Inotersen Nears Finish Line

Ionis will file polyneuropathy candidate in US and EU on its own, while GSK de-emphasizes rare diseases. Aclaris buys Confluence in earn-out-heavy deal, and Galena undertakes reverse merger with Sellas.

Deals M & A

Finance Watch: Canaan Closes New VC Fund; CARB-X Backs More Antibiotics

Canaan raised $800m for tech and health care investments. Also, six companies closed VC rounds, CARB-X backed more antibiotics, CIRM funded BrainStorm and Sarepta led recent offerings.

Financing Business Strategies

Appointments: ThermiGen, ReForm Biologics, Hookipa Biotech and Faron

This week’s roundup includes high-level appointments by Almirall, Hookipa Biotech and RXi Pharmaceuticals, in addition to CEO appointments by Karolinska Development and ReForm Biologics and various board announcements by companies including Faron and Redx.

Appointments BioPharmaceutical

Start-Up Previews, February 2016

In this month's issue of Start-Up, we profile Biolectrics, DigiSight Technologies, Redx Pharma and Woven Orthopedics.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Orexigen Therapeutics Inc.
  • Senior Management
  • Michael Narachi, Pres. & CEO
    Jason Keyes, SVP, CFO
    Thomas Cannell, EVP, COO & Pres., Global Commercial Products
    Peter Flynn, SVP & Head, Dev., Regulatory Affairs & Safety
  • Contact Info
  • Orexigen Therapeutics Inc.
    Phone: (858) 875-8600
    3344 N. Torrey Pines Ct., Ste. 200
    La Jolla, CA 92037
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register